This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovations of Ming Xue
Introduction
Ming Xue is an accomplished inventor based in Newtown, CT. He has made significant contributions to the field of biotechnology, particularly in the area of immunology. His work focuses on the development of novel therapeutic approaches for autoimmune and inflammatory diseases.
Latest Patents
Ming Xue holds a patent for "T cell proteins and nucleotides encoding the same." This invention relates to mouse and human J12 polynucleotides, polypeptides, and anti-J12 antibody molecules. The J12 is a cytokine that is preferentially expressed in Th2 cells. The polypeptides and/or antibodies described in this patent can be utilized in methods for the detection and treatment of certain autoimmune and inflammatory diseases, including asthma. He has 1 patent to his name.
Career Highlights
Ming Xue is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc., where he continues to advance his research in immunology. His work has the potential to impact the treatment of various diseases significantly.
Collaborations
Ming has collaborated with notable colleagues, including Jianfei Yang and Frank James King. Their combined expertise contributes to the innovative research environment at Boehringer Ingelheim.
Conclusion
Ming Xue's contributions to biotechnology and immunology exemplify the impact of innovative research on healthcare. His patent on J12 polynucleotides and polypeptides highlights the potential for new treatments for autoimmune diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile